Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
The sections below walk through each step in detail, starting with what makes retatrutide fundamentally different from other weight loss peptides on the market
Understanding this hierarchy helps set realistic expectations and guides protocol decisions
Administration Routes: Intramuscular vs
In the Phase 2 clinical trial (NEJM, 2023), retatrutide was administered subcutaneously at doses ranging from approximately 0.5 mg to 12 mg per week, with dose escalation under close medical supervision
Drug interactions represent another area of uncertainty
Contra-indications Individuals who have the following: Kidney and liver problems Heart problems or conditions Any person undergoing medical treatment Cancer patients Allergies/allergy to the product Pregnancy Breastfeeding Do vitamin injections help
